CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for GC Cell Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

GC Cell Corp
107, Ihyeon-ro 30beon-gil, Giheung-gu
Phone: +82 312609300p:+82 312609300 YONGIN, 16924  South Korea Ticker: 144510144510
This is a Subsidiary, click here for the Parent Company
Business Summary
GC Cell Corp is a Korea-based company principally engaged in the provision of specimen testing services. The Company is principally engaged in the provision of specimen testing services, which are all types of tests performed using specimens collected from patients for the purpose of diagnosing, preventing and treating diseases. The Company is engaged in the development, research, manufacture and distribution of cell therapy products. In addition, the Company is also engaged in the cord blood storage businesses and bio logistic businesses.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024Yes----

Industries
SIC Code Description
8071 Medical laboratories
8099 Health and allied services, not elsewhere classified
2836 Biological products, except diagnostic substances
4213 Trucking, except local

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Seong YongWon 53 11/29/2024 1/1/2023
Chief Technology Officer, Managing Director Ho WonKim 50 3/28/2023 3/28/2023
Chief Administrative Officer, Assistant Managing Director Chang HwiLee 50 1/1/2023 1/1/2022
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 427 (As of 6/30/2019)
Outstanding Shares: 15,027,141 (As of 12/31/2024)
Shareholders: 42,423
Stock Exchange: KDQ
Fax Number: +82 312609232


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 28, 2025